Massachusetts · 1,497 published self-pay prices, from $744 to $805,254.
These items are published without a standard CPT or HCPCS code, so they cannot be reliably matched against the same service at another hospital. They are shown exactly as this facility published them, and are excluded from every median, average and comparison elsewhere on this site.
Showing the 300 lowest-priced of 1,497 published items.
| Item | Cash price | Setting |
|---|---|---|
| ABATACEPT (WITH MALTOSE) 250 MG INTRAVENOUS SOLUTION [70287] | $4,692 | Both |
| ABOBOTULINUMTOXINA 300 UNIT INTRAMUSCULAR SOLUTION [106761] | $1,694 | Both |
| ABOBOTULINUMTOXINA 500 UNIT INTRAMUSCULAR SOLUTION [99465] | $2,843 | Both |
| ADO-TRASTUZUMAB EMTANSINE 100 MG INTRAVENOUS SOLUTION [120086] | $12,824 | Both |
| ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION [120087] | $20,746 | Both |
| AFLIBERCEPT 2 MG/0.05 ML INTRAVITREAL SOLUTION FOR INJECTION [112992] | $6,012 | Both |
| AFLIBERCEPT 2 MG/0.05 ML INTRAVITREAL SYRINGE [191417] | $6,012 | Both |
| AFLIBERCEPT 8 MG/0.07 ML INTRAVITREAL SOLUTION FOR INJECTION [204058] | $8,160 | Both |
| AGALSIDASE BETA 35 MG INTRAVENOUS SOLUTION [35775] | $20,319 | Both |
| AGALSIDASE BETA 5 MG INTRAVENOUS SOLUTION [38494] | $3,047 | Both |
| ALBUTEROL 90 MCG-BUDESONIDE 80 MCG/ACTUATION HFA AEROSOL INHALER [203828] | $1,469 | Both |
| ALGLUCOSIDASE ALFA 50 MG INTRAVENOUS SOLUTION [76353] | $2,732 | Both |
| ALPHA-1-PROTEINASE INHIBITOR (HUMAN) 1,000 MG (+/-)/20 ML IV SOLUTION [186187] | $1,495 | Both |
| ALPHA-1-PROTEINASE INHIBITOR (HUMAN) 1,000 MG INTRAVENOUS SOLUTION [36577] | $1,616 | Both |
| ALPHA-1-PROTEINASE INHIBITOR (HUMAN) 4,000 MG INTRAVENOUS SOLUTION [205344] | $4,177 | Both |
| ALTEPLASE 100 MG INTRAVENOUS SOLUTION [9002] | $27,600 | Both |
| ALTEPLASE 50 MG INTRAVENOUS SOLUTION [9003] | $13,800 | Both |
| AMINOCAPROIC ACID 250 MG/ML (25 %) ORAL SOLUTION [9062] | $828 | Both |
| AMINOLEVULINIC ACID HCL 30 MG/ML ORAL SOLUTION [188282] | $10,387 | Both |
| AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION [195491] | $11,911 | Both |
| ANGIOTENSIN II 2.5 MG/ML INTRAVENOUS SOLUTION [186196] | $5,608 | Both |
| ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION [197269] | $17,065 | Both |
| ANTI-INHIBITOR COAGULANT COMPLEX 700 UNIT-1,300 UNIT INTRAVENOUS SOLN [190838] | $6,045 | Both |
| ANTI-INHIBITOR COAGULANT COMPLX 1,750 UNIT-3,250 UNIT INTRAVENOUS SOLN [128157] | $13,847 | Both |
| ANTI-THYMOCYTE GLOBULIN (RABBIT) 25 MG INTRAVENOUS SOLUTION [24585] | $3,583 | Both |
| ANTIHEMOPHIL REC FAC VIII FC-VWF-XTEN (ALTUVIIIO) 1000 (+/-) UNIT IV SOLUTION [202468] | $16,644 | Both |
| ANTIHEMOPHIL REC FAC VIII FC-VWF-XTEN (ALTUVIIIO) 4000 (+/-) UNIT IV SOLUTION [202471] | $73,848 | Both |
| ANTIHEMOPHIL REC FAC VIII FC-VWF-XTEN (ALTUVIIIO) 500 (+/-) UNIT IV SOLUTION [202467] | $8,338 | Both |
| ANTIHEMOPHILIC FACTOR VIII (ADVATE/KOVALTRY/KOGENATE FS) FULL LENGTH 1,000 (+/-) UNIT IV SOLUTION [76367] | $3,431 | Both |
| ANTIHEMOPHILIC FACTOR VIII (ADVATE/KOVALTRY/KOGENATE FS) FULL LENGTH 500 (+/-) UNIT IV SOLUTION [76366] | $1,745 | Both |
| ANTIHEMOPHILIC FACTOR-VWF (HUMATE-P) 1,000 UNIT-2,400 UNIT INTRAVENOUS SOLUTION [70406] | $6,784 | Both |
| ANTIHEMOPHILIC FACTOR-VWF (HUMATE-P) 500 UNIT-1,200 UNIT INTRAVENOUS SOLUTION [70405] | $3,152 | Both |
| ANTIHEMOPHILIC FACTOR-VWF RECOMB (VONVENDI) 1,300 (+/-) UNIT RANGE INTRAVENOUS SOLN [180613] | $7,654 | Both |
| ANTIHEMOPHILIC FACTOR-VWF RECOMB (VONVENDI) 650 (+/-) UNIT RANGE INTRAVENOUS SOLN [180614] | $3,419 | Both |
| ANTITHROMBIN III (HUMAN) 500 (+/-) UNIT INTRAVENOUS SOLUTION [9116] | $6,302 | Both |
| APALUTAMIDE 240 MG TABLET [201874] | $1,365 | Both |
| ARGININE 25 MG-LYSINE 25MG/ML IN STERILE WATER INTRAVENOUS SOLUTION [189283] | $959 | Both |
| ARIPIPRAZOLE ER 300 MG INTRAMUSCULAR SUSPENSION,EXTENDED RELEASE [120172] | $6,346 | Both |
| ARIPIPRAZOLE ER 400 MG INTRAMUSCULAR SUSPENSION,EXTENDED RELEASE [120173] | $8,462 | Both |
| ARIPIPRAZOLE LAUROXIL ER 882 MG/3.2 ML SUSPENSION, EXT.REL. IM SYRINGE [177248] | $8,043 | Both |
| ARTESUNATE 110 MG INTRAVENOUS SOLUTION [194209] | $16,139 | Both |
| ASCORBIC ACID (VITAMIN C) 500 MG/ML INTRAVENOUS SOLUTION [186153] | $812 | Both |
| ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION [180147] | $35,644 | Both |
| ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION [189592] | $23,891 | Both |
| AVACINCAPTAD PEGOL (PF) 2 MG/0.1 ML INTRAVITREAL SOLUTION [203984] | $6,825 | Both |
| AVALGLUCOSIDASE ALFA-NGPT 100 MG INTRAVENOUS SOLUTION [197292] | $6,329 | Both |
| AVELUMAB 20 MG/ML INTRAVENOUS SOLUTION [182857] | $6,151 | Both |
| AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION [210270] | $15,356 | Both |
| AXITINIB 5 MG TABLET [113624] | $14,841 | Both |
| BASILIXIMAB 20 MG INTRAVENOUS SOLUTION [23082] | $14,143 | Both |
| BELATACEPT 250 MG INTRAVENOUS SOLUTION [110675] | $2,909 | Both |
| BELIMUMAB 120 MG INTRAVENOUS SOLUTION [108842] | $2,038 | Both |
| BELIMUMAB 400 MG INTRAVENOUS SOLUTION [108843] | $6,804 | Both |
| BELUMOSUDIL 200 MG TABLET [196979] | $1,151 | Both |
| BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLN (BELRAPZO) [606226] | $7,799 | Both |
| BENDAMUSTINE 25 MG/ML INTRAVENOUS SOLUTION (BENDEKA) [4080000003] | $5,431 | Both |
| BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE [185590] | $16,001 | Both |
| BETAXOLOL 0.25 % EYE DROPS,SUSPENSION [19703] | $937 | Both |
| BEVACIZUMAB 12.5MG/0.5ML INTRALESIONAL INJECTION [4080261393] | $2,590 | Both |
| BEVACIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [108065] | $10,473 | Both |
| BEVACIZUMAB-AWWB 25 MG/ML INTRAVENOUS SOLUTION [190450] | $1,400 | Both |
| BEVACIZUMAB-MALY 25 MG/ML INTRAVENOUS SOLUTION [199349] | $2,254 | Both |
| BEZLOTOXUMAB 25 MG/ML INTRAVENOUS SOLUTION [182025] | $12,350 | Both |
| BLINATUMOMAB 35 MCG INTRAVENOUS KIT [172805] | $16,797 | Both |
| BLINATUMOMAB 35 MCG INTRAVENOUS SOLUTION [183859] | $16,722 | Both |
| BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION [111348] | $37,733 | Both |
| BRIVARACETAM 10 MG/ML ORAL SOLUTION [180026] | $4,374 | Both |
| BUPRENORPHINE ER 100 MG/0.5 ML SOLUTION,EXTEN.REL.SUBCUTANEOUS SYRINGE [185846] | $6,242 | Both |
| BUPRENORPHINE ER 300 MG/1.5 ML SOLUTION,EXTEN.REL.SUBCUTANEOUS SYRINGE [185845] | $3,277 | Both |
| C1 ESTERASE INHIBITOR 500 UNIT (10 ML) INTRAVENOUS SOLUTION [132437] | $10,664 | Both |
| C1 ESTERASE INHIBITOR 500 UNIT (5 ML) INTRAVENOUS SOLUTION [94225] | $9,145 | Both |
| CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION [105644] | $45,075 | Both |
| CABOTEGRAVIR ER 400 MG/2 ML-RILPIVIRINE ER 600 MG/2ML IM SUSPENSION,ER [194877] | $14,710 | Both |
| CABOTEGRAVIR ER 600 MG/3 ML (200 MG/ML) IM SUSPENSION,EXTENDED RELEASE [198211] | $10,604 | Both |
| CABOTEGRAVIR ER 600 MG/3 ML-RILPIVIRINE ER 900 MG/3ML IM SUSPENSION,ER [195061] | $21,816 | Both |
| CALCITONIN (SALMON) 200 UNIT/ML INJECTION SOLUTION [9347] | $1,922 | Both |
| CANGRELOR 50 MG INTRAVENOUS SOLUTION [175955] | $2,850 | Both |
| CANNABIDIOL 100 MG/ML ORAL SOLUTION [188306] | $3,235 | Both |
| CAPLACIZUMAB-YHDP 11 MG INJECTION KIT [189274] | $26,335 | Both |
| CARFILZOMIB 10 MG INTRAVENOUS SOLUTION [187719] | $1,823 | Both |
| CARFILZOMIB 30 MG INTRAVENOUS SOLUTION [180437] | $5,494 | Both |
| CARFILZOMIB 60 MG INTRAVENOUS SOLUTION [117047] | $11,006 | Both |
| CEFTAZIDIME-AVIBACTAM 2.5 GRAM INTRAVENOUS SOLUTION [174843] | $1,160 | Both |
| CEFUROXIME(PF) 4 MG/0.4 ML IN 0.9% SODIUM CHLORIDE INTRAOCULAR SYRINGE [207800] | $13,321 | Both |
| CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION [188341] | $34,180 | Both |
| CERTOLIZUMAB PEGOL 400 MG/2 ML (200 MG/ML X2) SUBCUTANEOUS SYRINGE KIT [97853] | $5,897 | Both |
| CETUXIMAB 100 MG/50 ML INTRAVENOUS SOLUTION [37989] | $2,518 | Both |
| CHG ABL1 GENE ANALYSIS KINASE DOMAIN VARIANTS | $1,020 | Both |
| CHG ANTIBODY HLA CLASS I HIGH DEFINITION PANEL QUAL | $1,140 | Both |
| CHG ANTIBODY HLA CLASS II HIGH DEFINITION PANEL QUAL | $1,147 | Both |
| CHG ANTIBODY ID RBC ANTIBODIES EA PANEL EA SERUM TQ | $933 | Both |
| CHG AUTOL BLD/COMPONENT COLLJ STORAGE SALVAGE | $2,611 | Both |
| CHG BCR/ABL1 OTHER BREAKPNT QUALITATIVE/QUANTITATIVE | $756 | Both |
| CHG BLOOD TYPE ANTIGEN DONOR REAGENT SERUM EACH | $933 | Both |
| CHG BLOOD TYPING RBC ANTIGENS OTH/THN ABO/RH D EACH | $933 | Both |
| CHG BONE MARROW SMEAR INTERPRETATION | $2,702 | Both |
| CHG BRCA1 BRCA2 GENE ALYS FULL SEQ FULL DUP/DEL ALYS | $7,523 | Both |
| CHG CAR ION CHNNLPATH DUP/DEL GN ALYS PANEL 2 GENES | $2,212 | Both |
| CHG CEBPA GENE ANALYSIS FULL GENE SEQUENCE | $852 | Both |
| CHG CFTR GENE ANALYSIS COMMON VARIANTS | $2,024 | Both |
| CHG CFTR GENE ANALYSIS KNOWN FAMILIAL VARIANTS | $2,680 | Both |
| CHG CHIMERISM W/COMP TO BASELINE W/CELL SELECTION EA | $986 | Both |
| CHG CHIMERISM W/COMP TO BASELINE W/O CELL SELECTION | $785 | Both |
| CHG CHRMSM COUNT 5 CELL 1KARYOTYPE BANDING | $930 | Both |
| CHG CULTURE TYPING ID BLD PTHGN&RESIST TYPING 6+TRGT | $768 | Both |
| CHG CYP2C19 GENE ANALYSIS COMMON VARIANTS | $1,026 | Both |
| CHG CYTOG ALYS CHRMOML ABNOR CPY NUMBER&SNP VRNT CGH | $8,508 | Both |
| CHG CYTOG GEN-WIDE ALYS HEM MAL STRUX VRNT&CNV OGM | $3,924 | Both |
| CHG CYTOGENOMIC NEOPLASIA MICROARRAY ANALYSIS | $4,084 | Both |
| CHG DRUG ASSAY CYCLOSPORINE | $820 | Both |
| CHG DRUG SCREEN QUANT ALCOHOLS BIOMARKERS 1 OR 2 | $1,632 | Both |
| CHG DRUG SCREENING FENTANYL | $1,643 | Both |
| CHG DRUG TST PRSMV INSTRMNT CHEM ANALYZERS PR DATE | $887 | Both |
| CHG ELECTRON MICROSCOPY DIAGNOSTIC | $2,800 | Both |
| CHG FETAL CHROMOSOMAL ANEUPLOIDY GENOMIC SEQ ANALYS | $2,672 | Both |
| CHG FLOW CYTOMETRY CELL SURF MARKER TECHL ONLY 1ST | $933 | Both |
| CHG FLT3 GENE ITD VARIANTS QUAN | $1,265 | Both |
| CHG GENETIC TESTING FOR SEVERE INHERITED CONDITIONS | $8,621 | Both |
| CHG HBB FULL GENE SEQUENCE | $1,143 | Both |
| CHG HEMATOLYMPHOID NEO/DO GSAP 5-50DNA/DNA&RNA ALYS | $2,673 | Both |
| CHG HERED NEUROEND TUM-RELATED DO GEN SEQ ALYS 5+ | $4,049 | Both |
| CHG HEREDITARY BRST CA-RLATD DO GEN SEQ ALYS 5+ GEN | $2,568 | Both |
| CHG HEREDITARY CARDIOMYOPATHY GEN SEQ ANALYS 5 GEN | $1,989 | Both |
| CHG HEREDITARY COLON CA-RELATED DO GEN SEQ ALYS 5+ | $4,049 | Both |
| CHG HEREDITARY PERIPHERAL NEUROPATHY GEN SEQ PNL | $2,212 | Both |
| CHG HLA CLASS I TYPING HIGH RESOLUTION COMPLETE | $1,141 | Both |
| CHG HLA CLASS I TYPING LOW RESOLUTION COMPLETE | $1,421 | Both |
| CHG IADNA RESPIRATRY PROBE & REV TRNSCR 12-25 TARGET | $1,614 | Both |
| CHG IADNA RESPIRATRY PROBE & REV TRNSCR 6-11 TARGETS | $807 | Both |
| CHG IADNA-DNA/RNA GI PTHGN MULTIPLEX PROBE TQ 12-25 | $1,576 | Both |
| CHG IADNA-DNA/RNA GI PTHGN MULTIPLEX PROBE TQ 6-11 | $926 | Both |
| CHG IDH2 COMMON VARIANTS | $1,041 | Both |
| CHG IGH@ REARRANGE ABNORMAL CLONAL POP AMPLIFIED | $748 | Both |
| CHG IGH@ VARIABLE REGION SOMATIC MUTATION ANALYSIS | $1,037 | Both |
| CHG IMHCHEM/IMCYTCHM EA MULTIPLEX ANTIBODY STAIN PX | $933 | Both |
| CHG IMMUNOFLUORESCENCE PER SPEC 1ST SINGLE ANTB STN | $1,213 | Both |
| CHG KIT GENE ANALYSIS TARGETED SEQUENCE ANALYSIS | $1,160 | Both |
| CHG LEVEL V SURG PATHOLOGY GROSS&MICROSCOPIC EXAM | $933 | Both |
| CHG LEVEL VI SURG PATHOLOGY GROSS&MICROSCOPIC EXAM | $2,100 | Both |
| CHG M/PHMTRC ALYS TUMOR IMHCHEM EA ANTBDY CMPTR ASST | $1,213 | Both |
| CHG MLH1 GENE ANALYSIS FULL SEQUENCE ANALYSIS | $2,377 | Both |
| CHG MLH1 GENE ANALYSIS PROMOTER METHYLATION ANALYSIS | $758 | Both |
| CHG MOLECULAR PATHOLOGY PROCEDURE LEVEL 5 | $1,019 | Both |
| CHG MOLECULAR PATHOLOGY PROCEDURE LEVEL 6 | $1,119 | Both |
| CHG MOLECULAR PATHOLOGY PROCEDURE LEVEL 7 | $1,095 | Both |
| CHG MOLECULAR PATHOLOGY PROCEDURE LEVEL 8 | $2,980 | Both |
| CHG MOLECULAR PATHOLOGY PROCEDURE LEVEL 9 | $7,041 | Both |
| CHG MSH2 GENE ANALYSIS DUPLICATION/DELETION VARIANTS | $751 | Both |
| CHG MSH2 GENE ANALYSIS FULL SEQUENCE ANALYSIS | $1,343 | Both |
| CHG MSH6 GENE ANALYSIS DUPLICATION/DELETION VARIA | $838 | Both |
| CHG MSH6 GENE ANALYSIS FULL SEQUENCE ANALYSIS | $2,259 | Both |
| CHG NEURO PRKNSN CSF DETCJ MSFLD A-SYNCLN PRTN QUAL | $1,623 | Both |
| CHG NFCT AGENT GENOTYPE ALYS NUCLEIC ACD HEP B VIRUS | $907 | Both |
| CHG NFCT AGT GENOTYPE ALYS NUCLEIC ACID CMV | $974 | Both |
| CHG NFCT AGT GNOTYP ALYS NUCLE ACD HIV1 REV TRNSCRPT | $974 | Both |
| CHG NFCT DS BCT VAGINOSIS&VAGINITIS DNA VAG FLU ALG | $895 | Both |
| CHG NFCT DS BV&VAGINITIS RTPCR AMP DNA MARKERS | $817 | Both |
| CHG NFCT DS MCRB CLL FR DNA UNTRGT NEXT GENRJ SEQ | $7,485 | Both |
| CHG NPM1 (NUCLEOPHOSMIN) (EG, ACUTE MYELOID LEUKEMIA) GENE ANALYSIS, QUANTITATIVE | $1,265 | Both |
| CHG NPM1 NUCLEOPHOSMIN GENE ANAL EXON 12 VARIANTS | $868 | Both |
| CHG NUCLEAR MITOCHONDRIAL 100 GENE GENOMIC SEQ | $11,306 | Both |
| CHG ONC HL NEO GEN SEQ ALYS ALG QUAN DMT CLNL SEQ | $6,022 | Both |
| CHG ONC PRST8 MRNA MICRORA GENE XPRSN PRFL 22 GENES | $13,635 | Both |
| CHG ONCOLOGY BREAST MRNA GENE EXPRESSION 11 GENES | $13,635 | Both |
| CHG PATH CONSLTJ SURG CYTOLOGIC EXAM INITIAL SITE | $2,100 | Both |
| CHG PLCG2 GENE ANALYSIS COMMON VARIANTS | $1,026 | Both |
| CHG PML/RARALPHA COMMON BREAKPOINTS QUAL/QUANT | $770 | Both |
| CHG PMP22 GENE ANAL DUPLICATION/DELETION ANALYSIS | $2,579 | Both |
| CHG PMS2 GENE ANALYSIS FULL SEQUENCE | $2,382 | Both |
| CHG PRETX RBC ANTIBODY INCUBAT W/DENSITY GRAD SEP | $1,258 | Both |
| CHG PRETX RBC ANTIBODY INCUBAT W/ENZYMES EACH | $1,180 | Both |
| CHG PTEN GENE ANALYSIS FULL SEQUENCE ANALYSIS | $2,041 | Both |
| CHG SO NEO GSAP CL FR DNA/DNA&RNA CPY NMBR MCRST INS | $10,211 | Both |
| CHG SO NEO GSAP DNA ALYS MICROSATELLITE INSTABILITY | $2,785 | Both |
| CHG SO NEO GSAP DNA ALYS/DNA&RNA CPY NMBR MCRSTL INS | $9,283 | Both |
| CHG SO/HEMATOLYMPHOID NEO/DO 51/>GSAP DNA/DNA&RNA | $10,279 | Both |
| CHG SPECIAL STAIN I&R GROUP III ENZYME CONSITUENTS | $2,689 | Both |
| CHG TGSAP SLD ORG NEO DNA 523&RNA 55 NEXT GNRJ SEQ | $10,211 | Both |
| CHG TRB@ REARRANGEMENT ANAL AMPLIFICATION METHOD | $939 | Both |
| CHG TRG@ GENE REARRANGEMENT ANALYSIS | $906 | Both |
| CHG TRNSPLN REJ KDN MRNA GENE XPRSN PRFLG QPCR 139 | $10,060 | Both |
| CHG UGT1A1 GENE ANALYSIS COMMON VARIANTS | $824 | Both |
| CHG WHOLE MITOCHONDRIAL GENOME | $4,378 | Both |
| CHG WHOLE MITOCHONDRIAL GENOME ANALYSIS PANEL | $3,184 | Both |
| CIDOFOVIR 75 MG/ML INTRAVENOUS SOLUTION [17378] | $1,470 | Both |
| COAGULATION FACTOR IX RECOMB (BENEFIX) 1,000 UNIT INTRAVENOUS SOLUTION [165539] | $3,379 | Both |
| COAGULATION FACTOR IX RECOMB (BENEFIX) 500 UNIT INTRAVENOUS SOLUTION [165538] | $1,628 | Both |
| COAGULATION FACTOR VIIA RECOMB 1 MG (1,000 MCG) INTRAVENOUS SOLUTION [92853] | $7,282 | Both |
| COAGULATION FACTOR VIIA RECOMB 2 MG (2,000 MCG) INTRAVENOUS SOLUTION [92854] | $14,564 | Both |
| COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 0.9 MG SOLUTION FOR INJECTION [101010] | $20,596 | Both |
| COLLAGENASE CLOSTRIDIUM HISTOLYTICUM 250 UNIT/GRAM TOPICAL OINTMENT [9682] | $856 | Both |
| CONJUGATED ESTROGENS 0.625 MG/GRAM VAGINAL CREAM [9977] | $1,381 | Both |
| CONJUGATED ESTROGENS 25 MG SOLUTION FOR INJECTION [9972] | $1,125 | Both |
| COPPER 380 SQUARE MM INTRAUTERINE DEVICE [165585] | $3,526 | Both |
| COPPER CU-64 DOTATATE 148 MBQ/4 ML (4 MCI/4 ML) INTRAVENOUS SOLUTION [194363] | $13,162 | Both |
| CRIZANLIZUMAB-TMCA 10 MG/ML INTRAVENOUS SOLUTION [191652] | $7,972 | Both |
| CYCLOPHOSPHAMIDE 1 GRAM INTRAVENOUS POWDER FOR SOLUTION [38270] | $885 | Both |
| CYCLOPHOSPHAMIDE 10 MG/ML ORAL SUSPENSION [601059] | $1,213 | Both |
| CYTOMEGALOVIRUS IMMUNE GLOBULIN 50 MG/ML INTRAVENOUS SOLUTION [14634] | $5,710 | Both |
| DACTINOMYCIN 0.5 MG INTRAVENOUS SOLUTION [28912] | $1,693 | Both |
| DALBAVANCIN 500 MG INTRAVENOUS SOLUTION [170013] | $5,076 | Both |
| DANTROLENE 250 MG INTRAVENOUS SUSPENSION [170644] | $7,756 | Both |
| DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN [192863] | $33,004 | Both |
| DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION [177582] | $2,300 | Both |
| DARBEPOETIN ALFA 100 MCG/0.5 ML IN POLYSORBATE INJECTION SYRINGE [108044] | $1,086 | Both |
| DARBEPOETIN ALFA 100 MCG/ML IN POLYSORBATE INJECTION [76965] | $1,092 | Both |
| DARBEPOETIN ALFA 150 MCG/0.3 ML IN POLYSORBATE INJECTION SYRINGE [108046] | $1,637 | Both |
| DARBEPOETIN ALFA 200 MCG/0.4 ML IN POLYSORBATE INJECTION SYRINGE [108047] | $2,183 | Both |
| DARBEPOETIN ALFA 200 MCG/ML IN POLYSORBATE INJECTION [76966] | $2,183 | Both |
| DARBEPOETIN ALFA 300 MCG/0.6 ML IN POLYSORBATE INJECTION SYRINGE [108048] | $3,274 | Both |
| DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE [76334] | $5,457 | Both |
| DARUNAVIR 100 MG/ML ORAL SUSPENSION [119037] | $3,896 | Both |
| DATOPOTAMAB DERUXTECAN-DLNK 100 MG INTRAVENOUS SOLUTION [210387] | $15,896 | Both |
| DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION [184735] | $33,150 | Both |
| DAXIBOTULINUMTOXINA-LANM 100 UNIT INTRAMUSCULAR SOLUTION [201457] | $1,363 | Both |
| DEGARELIX 120 MG SUBCUTANEOUS SOLUTION [96987] | $1,487 | Both |
| DEGARELIX 80 MG SUBCUTANEOUS SOLUTION [96986] | $953 | Both |
| DENOSUMAB 120 MG/1.7 ML (70 MG/ML) SUBCUTANEOUS SOLUTION [106804] | $10,490 | Both |
| DENOSUMAB 60 MG/ML SUBCUTANEOUS SYRINGE [105502] | $5,447 | Both |
| DEXAMETHASONE 0.7 MG INTRAVITREAL IMPLANT [99461] | $4,462 | Both |
| DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION [31432] | $13,800 | Both |
| DIMETHYL SULFOXIDE 50 % INTRAVESICAL SOLUTION [129967] | $2,216 | Both |
| DONANEMAB-AZBT 17.5 MG/ML INTRAVENOUS SOLUTION [207840] | $2,261 | Both |
| DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [195370] | $37,889 | Both |
| DOXORUBICIN 50 MG INTRAVENOUS SOLUTION [2619] | $750 | Both |
| DOXORUBICIN CONVENTIONAL TACE 50 MG/10 ML PREMIX SYRINGE [632415] | $7,502 | Both |
| DOXORUBICIN, PEGYLATED LIPOSOMAL 2 MG / ML DESENSITIZATION INTRAVENOUN [4080261166] | $1,003 | Both |
| DOXORUBICIN, PEGYLATED LIPOSOMAL 2 MG/ML INTRAVENOUS SUSPENSION [27431] | $1,591 | Both |
| DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION [183738] | $13,491 | Both |
| ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION [81696] | $19,786 | Both |
| EDETATE DISODIUM (EDTA) 1.5% (15 MG/ML) OPHTHALMIC SOLUTION [972088] | $19,374 | Both |
| EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION [198206] | $19,989 | Both |
| ELOTUZUMAB 300 MG INTRAVENOUS SOLUTION [177828] | $7,396 | Both |
| ELOTUZUMAB 400 MG INTRAVENOUS SOLUTION [177829] | $9,861 | Both |
| ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION [204034] | $22,324 | Both |
| ELTROMBOPAG OLAMINE 50 MG TABLET [94580] | $1,477 | Both |
| ELTROMBOPAG OLAMINE 75 MG TABLET [104003] | $1,347 | Both |
| EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION [188903] | $54,876 | Both |
| EMICIZUMAB-KXWH 105 MG/0.7 ML SUBCUTANEOUS SOLUTION [185605] | $38,202 | Both |
| EMICIZUMAB-KXWH 150 MG/ML SUBCUTANEOUS SOLUTION [185606] | $53,047 | Both |
| EMICIZUMAB-KXWH 30 MG/ML SUBCUTANEOUS SOLUTION [185603] | $10,609 | Both |
| EMICIZUMAB-KXWH 300 MG/2 ML (150 MG/ML) SUBCUTANEOUS SOLUTION [205824] | $110,809 | Both |
| EMICIZUMAB-KXWH 60 MG/0.4 ML SUBCUTANEOUS SOLUTION [185604] | $21,268 | Both |
| ENASIDENIB 100 MG TABLET [184694] | $1,425 | Both |
| ENFORTUMAB VEDOTIN-EJFV 20 MG INTRAVENOUS SOLUTION [191768] | $9,077 | Both |
| ENFORTUMAB VEDOTIN-EJFV 30 MG INTRAVENOUS SOLUTION [191769] | $13,628 | Both |
| ENTECAVIR 0.05 MG/ML ORAL SOLUTION [41149] | $2,966 | Both |
| EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION [202909] | $51,582 | Both |
| EPINEPHRINE 2 MG IN 250 ML (8 MCG/ML) EMERGENCY DRIP KIT (FOR DILUTION) [972265] | $2,457 | Both |
| EPOETIN ALFA 20,000 UNIT/ML INJECTION SOLUTION [14643] | $1,049 | Both |
| EPOETIN ALFA 40,000 UNIT/ML INJECTION SOLUTION [24513] | $2,097 | Both |
| EPOETIN ALFA-EPBX 40,000 UNIT/ML INJECTION SOLUTION [187243] | $1,179 | Both |
| EPTINEZUMAB-JJMR 100 MG/ML INTRAVENOUS SOLUTION [192640] | $6,002 | Both |
| ERIBULIN 1 MG/2 ML (0.5 MG/ML) INTRAVENOUS SOLUTION [106773] | $2,161 | Both |
| ESKETAMINE 28 MG NASAL SPRAY [189567] | $2,385 | Both |
| ESKETAMINE 56 MG (28 MG X 2) NASAL SPRAY [189568] | $2,271 | Both |
| ESKETAMINE 84 MG (28 MG X 3) NASAL SPRAY [189569] | $2,101 | Both |
| ETANERCEPT 25 MG/0.5 ML (0.5 ML) SUBCUTANEOUS SYRINGE [108125] | $2,989 | Both |
| ETANERCEPT 25 MG/0.5 ML SUBCUTANEOUS SOLUTION [193617] | $2,262 | Both |
| ETANERCEPT 50 MG/ML (1 ML) SUBCUTANEOUS SYRINGE [39837] | $5,804 | Both |
| ETHACRYNATE SODIUM 50 MG INTRAVENOUS SOLUTION [9979] | $1,531 | Both |
| ETHANOL 70% CATHETER LOCK [410100] | $2,523 | Both |
| ETHIODIZED OIL 480 MG IODINE/ML FOR INJECTION [169252] | $4,654 | Both |
| ETONOGESTREL 68 MG SUBDERMAL IMPLANT [77012] | $1,614 | Both |
| FACTOR XA,INACTIVATED-ZHZO (RECOMBINANT) 200 MG INTRAVENOUS SOLUTION [189214] | $8,125 | Both |
| FACTOR XIII 1,000 UNIT-1,600 UNIT INTRAVENOUS SOLUTION [108721] | $39,663 | Both |
| FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG INTRAVENOUS SOLUTION [191775] | $9,351 | Both |
| FARICIMAB-SVOA 6 MG/0.05 ML INTRAVITREAL WRAPPER [339688] | $7,118 | Both |
| FERRIC DERISOMALTOSE 100 MG IRON/ML INTRAVENOUS SOLUTION [194166] | $7,577 | Both |
| FIBRINOGEN 1 GRAM (700 MG-1,300 MG) INTRAVENOUS SOLUTION [185896] | $2,733 | Both |
| FIBRINOGEN 1 GRAM (900 MG-1,300 MG) INTRAVENOUS SOLUTION [96989] | $4,409 | Both |
| FILGRASTIM 300 MCG/ML INJECTION SOLUTION [10036] | $986 | Both |
| FILGRASTIM 480 MCG/1.6 ML INJECTION SOLUTION [108074] | $1,571 | Both |
| FILGRASTIM-SNDZ 480 MCG/0.8 ML INJECTION SYRINGE [176722] | $1,144 | Both |
| FLORBETAPIR F-18 10 MCI (370 MBQ) INTRAVENOUS SOLUTION [116128] | $9,396 | Both |
| FLOTUFOLASTAT F 18 296-5,846 MBQ/ML (8-158 MCI/ML) IV SOLUTION [202962] | $15,977 | Both |
| FLUOROESTRADIOL F-18 148 MBQ/ML TO 3,700 MBQ/ML INTRAVENOUS SOLUTION [194208] | $14,999 | Both |
| FLUTICASONE PROPIONATE 220 MCG/ACTUATION HFA AEROSOL INHALER [40699] | $1,000 | Both |
| FOMEPIZOLE 1 GRAM/ML INTRAVENOUS SOLUTION [22185] | $1,535 | Both |
| FOSCARNET 2.4 MG/0.1 ML INTRAVITREAL INJECTION [978566] | $1,000 | Both |
| GANCICLOVIR 0.15 % EYE GEL [104575] | $1,422 | Both |
| GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN [184975] | $32,647 | Both |
| GILTERITINIB 40 MG TABLET [188585] | $745 | Both |
| GLOFITAMAB-GXBM 1 MG/ML INTRAVENOUS SOLUTION [203050] | $8,529 | Both |
| GLUCAGON 3 MG/ACTUATION NASAL SPRAY [190561] | $841 | Both |
| GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION [116024] | $125,060 | Both |
| GOLIMUMAB 12.5 MG/ML INTRAVENOUS SOLUTION [165644] | $6,267 | Both |
| GOSERELIN 10.8 MG SUBCUTANEOUS IMPLANT [16254] | $9,057 | Both |
| GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION [208776] | $47,317 | Both |
| HC INJ DX THER SBST INTRLMNR CRV THRC W IMG GDN | $2,046 | Both |
| HC INJ DX THER SBST INTRLMNR CRV THRC W O IMG GDN | $2,467 | Both |
| HC INJ DX THER SBST INTRLMNR LMBR SAC W IMG GDN | $2,046 | Both |
| HC INJ DX THER SBST INTRLMNR LMBR SAC W O IMG GDN | $2,696 | Both |
| HC SIM ANG W/PRS CATH RAD EMB | $35,213 | Both |
| HC 3D CT RENDERING W INTER AND POSTPROCESS SUPERVISION | $1,760 | Both |
| HC 3D RADIOTHERAPY PLAN DOSE VOL HISTOGRAMS | $5,674 | Both |
| HC 3D RENDERING W INTER AND POSTPROCESS SUPERVISION | $1,760 | Both |
| HC 3D ULTRASOUND RENDERING W INTER AND POSTPROCESS SUPERVISION | $1,760 | Both |
| HC ABDOM PARACENTESIS DIAG OR THER W IMG GUIDE | $1,279 | Both |
| HC ABDOM PARACENTESIS DIAG OR THER WO IMG GUIDE | $2,682 | Both |
For procedures with standard CPT codes — where prices can be compared across hospitals — see prices in Massachusetts or browse all procedures.